Journal of Gastrointestinal Oncology

Papers
(The TQCC of Journal of Gastrointestinal Oncology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Stage cT3 low rectal cancer: analysis of prognostic factors47
Anatomical observation and clinical significance of the left gastric vein in laparoscopic radical gastrectomy28
Gelatin sponge microparticles for transarterial chemoembolization combined with regorafenib in hepatocellular carcinoma: a single-center retrospective study25
Construction and validation of a prognostic nomogram for locally recurrent rectal cancer: a population-based study25
Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment i25
An unusual presentation of solitary ovarian metastasis from colorectal cancer in an elderly woman: a case report24
The prognostic value of the number of metastatic lymph nodes on the long-term survival of intrahepatic cholangiocarcinoma using the SEER database23
Transforming hyperthermic intraperitoneal chemotherapy: using computer simulation to improve HIPEC treatments23
Prognostic nomogram for T3–T4 primary colorectal cancer patients with perineural invasion after surgery: a Surveillance, Epidemiology, and End Results program database analysis22
Pattern of distant metastases and predictive nomograms in colorectal mucinous adenocarcinoma: a SEER analysis22
A narrative review of intraoperative use of indocyanine green fluorescence imaging in gastrointestinal cancer: situation and future directions21
The unique role of cuproptosis in the prognosis and treatment of rectum adenocarcinoma21
Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study21
Lactic acid: a narrative review of a promoter of the liver cancer microenvironment21
Rectal tumor fragmentation as a response pattern following chemoradiation20
Clinical features and prognostic factors of patients with inoperable hepatocellular carcinoma treated with chemotherapy: a population-based study20
Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma20
Combined hepatocellular carcinoma-cholangiocarcinoma with sarcomatoid features: new insights into a rare and aggressive tumor19
Prediction of early recurrence in patients with colorectal liver metastases19
CBX3 is associated with metastasis and glutathione/glycosphingolipid metabolism in colon adenocarcinoma18
Treatment paradigms and survival outcomes in esophageal adenocarcinoma with liver metastasis: a retrospective cohort study using the SEER database17
Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospecti16
Emerging role of circulating tumor DNA for early detection of recurrence in biliary tract cancers15
Clinical outcome of non-curative endoscopic submucosal dissection for early gastric cancer15
Bioinformatics analysis identifying FBXO45 gene as a potential oncogene in esophageal cancer15
LDHA as a predictive biomarker and its association with the infiltration of immune cells in pancreatic adenocarcinoma15
Latin American young patients with gastric adenocarcinoma: worst prognosis and outcomes15
MMP11 as a prognostic biomarker correlated with immune infiltrates in pancreatic adenocarcinoma15
Liquid-liquid phase separation-related features of PYGB/ACTR3/CCNA2/ITGB1/ATP8A1/RAP1GAP2 predict the prognosis of pancreatic cancer15
Determining the optimal number of examined lymph nodes for prognosis in colon cancer: a population-based study stratified by tumor location and T stage14
Validating the PSOGI classification of peritoneal disease from non-carcinoid epithelial appendiceal neoplasms in the curative and palliative setting: an observational retrospective study14
Effect of perioperative blood transfusion (BTF) on elderly gastric cancer patients14
Pancreatic cancer mortality trends in the United States: how much have we moved the needle?14
Erratum to Construction and validation of a predictive model for the risk of three-month-postoperative malnutrition in patients with gastric cancer: a retrospective case-control study14
Sarcomatoid change in combined hepatocellular carcinoma and cholangiocarcinoma as a poor prognostic factor14
What is the significance of mismatch repair deficiency in stage IV colon cancer?14
Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocol13
Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank13
Identification of methyltransferase-like protein 11B as a new prognostic biomarker for colorectal cancer through an analysis of The Cancer Genome Atlas13
Influence of pre-operative sarcopenia on post-operative hepatic steatosis after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma13
Insights and recommendations for enhancing the prognostic nomogram in elderly patients with stage II–III colorectal cancer13
A real-world study of oxaliplatin-induced hypersensitivity in colorectal cancer treatment based on the pharmacovigilance system in China: a cohort study12
A novel robust nomogram based on preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) for predicting lymph node metastasis of gastric cancer12
A bioinformatics analysis of potential cellular communication networks in non-alcoholic steatohepatitis and colorectal adenoma using scRNA-seq and bulk-seq12
Radiomics based on machine learning algorithms could predict prognosis and postoperative chemotherapy benefits of patients with gastric cancer: a retrospective cohort study12
Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients12
Duodenal neuroendocrine tumors: how safe is endoscopic resection?12
Does chemotherapy regimen matter in the neoadjuvant treatment of esophageal cancer?12
KCNC3 as a prognostic indicator and a predictive marker for immunotherapy in colorectal cancer12
Path towards personalized care of hepatocellular carcinoma: a nomogram for survival prediction12
LRG1 in pancreatic cancer cells promotes inflammatory factor synthesis and the angiogenesis of HUVECs by activating VEGFR signaling12
Another hammer, but we need a wrench, and a screwdriver—positron emission tomography/magnetic resonance imaging represents another tool for post-delivery 90Y dosimetry, but what are we still missing?12
Sarcopenia with systemic inflammation can predict survival in patients with hepatocellular carcinoma undergoing curative resection12
Liver transplantation in a patient with metastatic hepatocellular carcinoma after downstaging with single-agent immunotherapy: the first case report11
The efficacy-associated biomarkers for immune checkpoint inhibitors in gastrointestinal cancer: a literature review11
The relationship between GLIM-malnutrition, post-operative complications and long-term prognosis in elderly patients undergoing colorectal cancer surgery11
Treatment at a high-volume academic research program mitigates racial disparities in pancreatic adenocarcinoma11
A narrative review of systemic treatment options for hepatocellular carcinoma: state of the art review11
Evaluation of the tumoricidal efficacy of adoptive cell transfer using hepatocellular carcinoma-derived organoids11
Construction and validation of a predictive model for the risk of three-month-postoperative malnutrition in patients with gastric cancer: a retrospective case-control study11
MiR-107 inhibits the malignant biological behavior of esophageal squamous cell carcinoma by targeting TPM311
Biomarker-driven therapeutic strategies in advanced gastric cancer: a case series of curative responses11
The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds11
Two autopsied gastric cancer cases of rare drug-induced pneumonia associated with nivolumab plus S-1 and oxaliplatin: a case report11
A comparison of two methods of lymph node dissection along the left recurrent laryngeal nerve in McKeown minimally invasive esophagectomy11
Risk of de novo esophageal cancer in liver transplant recipients: systematic review and meta-analysis11
Gastric and colorectal cancer incidence attributable to dietary factors in Korea11
Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis11
A bioinformatics analysis and an experimental validation of the hypoxia-related prognostic model11
Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome10
Nestin overexpression reduces the sensitivity of gastric cancer cells to trastuzumab10
Increasing colorectal cancer screening uptake—time to consider a more holistic socio-ecological approach10
Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer10
Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin10
A randomized trial of negative pressure wound therapy technology combined with intermittent instillation in the treatment of neck anastomotic leakage after esophageal cancer surgery10
Mismatch repair deficiency confers worse survival in stage IV colon cancer10
Circ_0000799 promotes proliferation and invasion in colorectal cancer and epithelial-mesenchymal transition10
A prognostic nomogram integrating carcinoembryonic antigen levels for predicting overall survival in elderly patients with stage II–III colorectal cancer10
Differential effect of tumor budding on the benefit of adjuvant chemotherapy in stage II colorectal cancer: a retrospective observational study10
Tripartite motif 52 (TRIM52) promotes proliferation, migration, and regulation of colon cancer cells associated with the NF-κB signaling pathway10
IL-1 receptor-associated kinase 1 participates in the modulation of the NLRP3 inflammasome by tumor-associated macrophages in hepatocellular carcinoma10
Prognostic performance of different lymph node classification systems in young gastric cancer10
Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer?10
Slug and CD133 expression are associated with peritoneal carcinomatosis and survival in gastric cancer10
Exosomal miR-125b-5p derived from cancer-associated fibroblasts promotes the growth, migration, and invasion of pancreatic cancer cells by decreasing adenomatous polyposis coli (APC) expression10
Locally advanced anal small cell carcinoma with durable complete response to chemoradiation followed by consolidation chemotherapy: case report and literature review10
Prognostic evaluation of a multi-target magnetic bead-enriched circulating tumor cell-enriched identification system for colorectal cancer10
Circulating tumor DNA analysis guiding adjuvant treatment in resected stage III cholangiocarcinoma: a case report10
Investigation of the accuracy of magnetic resonance cholangiography and multi-slice spiral computed tomography in the diagnosis of cholangiocarcinoma10
Immunotherapy in synchronous MSI-H rectal adenocarcinoma and upper tract urothelial carcinoma: a case report10
The clinical effect of conversion surgery for advanced gastric cancer patients with peritoneal metastasis9
Efficacy and safety of transcatheter arterial chemoembolization-lenvatinib sequential therapy for patients with unresectable hepatocellular carcinoma: a single-arm clinical study9
Development and experimental validation of a senescence-related long non-coding RNA signature for prognostic prediction and immune microenvironment characterization in gastric cancer patients9
Unexpected plasmablastic lymphoma in a young adult with unknown HIV infection: case report9
PANoptosis-associated genes exhibit significant potential in the diagnosis of hepatocellular carcinoma9
MiR-873-5p targets THUMPD1 to inhibit gastric cancer cell behavior and chemoresistance9
Efficacy and safety of transarterial chemoembolization alone compared to its combination with anlotinib among patients with intermediate or advanced stage hepatocellular carcinoma: a phase II randomiz9
Study on efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with regorafenib and PD-1 antibody versus continued TACE combined with regorafenib in patients with hepatocellu9
Development and validation of a nomogram to predict cancer-specific survival of patients with large hepatocellular carcinoma accepting surgical resection: a real-world analysis based on the SEER datab9
Impact of prolonged surgical waiting time on cancer-specific mortality in stage I–II pancreatic ductal adenocarcinoma patients who received radical resection9
Peripheral blood neutrophil-to-lymphocyte ratio as a prognostic marker and its association with the tumor-immune microenvironment in pancreatic cancer: a retrospective cohort study9
Camrelizumab in combination with chemotherapy and targeted therapy improves the prognosis in patients with advanced biliary tract cancer: a single-center retrospective clinical study9
Integrating T-cell inflammation features for prognosis in hepatocellular carcinoma: a novel predictive model9
A novel miRNA-based model for predicting the 3-year recurrence risk of hepatocellular carcinoma following liver transplantation9
Is the transverse colon the new right?—similarities in EGFR drug response and prognosis9
Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignancies9
Identification and validation of a ferroptosis-related long non-coding RNA signature as a prognostic biomarker for hepatocellular carcinoma9
Compared to preoperative plasma levels post-operative urokinase-type plasminogen activator-1 levels are persistently elevated for 6 weeks after minimally invasive colorectal resection9
Development and validation of machine learning models for postoperative venous thromboembolism prediction in colorectal cancer inpatients: a retrospective study8
Role of chemoradiation in gallbladder cancer—a single institution retrospective analysis8
Tumor mutation burden in gastro-entero-pancreatic-neuroendocrine neoplasms8
PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-68
Multi-omics analyses develop and validate the optimal prognostic model on overall survival prediction for resectable hepatocellular carcinoma8
Clinical characteristics, survival and prognostic nomogram for patients with esophageal mucinous adenocarcinoma: a SEER population-based analysis8
Conversion surgery by hand-assisted laparoscopic surgery following chemotherapy for rectal cancer with H3 liver metastases: a case report8
Radiofrequency ablation has similar short-term effects but significantly lowers the long-term effect compared with routine resection in the treatment of small hepatocellular carcinoma8
Rare germline chromosome 1 duplication identified in young male with colon cancer: a case report investigating causality8
Bioinformatical identification of key genes regulated by IGF2BP2- mediated RNA N6-methyladenosine and prediction of prognosis in hepatocellular carcinoma8
Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: a retrospective st8
Time-trends in liver cancer incidence and mortality rates in the U.S. from 1975 to 2017: a study based on the Surveillance, Epidemiology, and End Results database8
Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study8
Development and validation of a LASSO-based nomogram for predicting anastomotic leakage in elderly patients after laparoscopic gastrectomy8
Function of hsa_circ_0006646 as a competing endogenous RNA to promote progression in gastric cancer by regulating the miR-665–HMGB1 axis8
Integrated omics analysis: the relationship between significantly increased Klebsiella post-hepatectomy and decreased hub-metabolite 3-methyl-2-oxobutanoic acid is associated with induced liver failur8
Negative hyperselection beyond RAS: is a key tool for choosing the optimal maintenance treatment in metastatic colorectal cancer?8
Potential molecular metabolic mechanisms underlying the effects of cimifugin in gastric cancer through single-cell and bulk RNA sequencing combined with network pharmacology8
Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System8
Clinical outcomes of definitive radiotherapy for patients with cT1aN0M0 esophageal cancer unsuitable for endoscopic resection and surgery8
Comparison of initial tumor responses to transarterial bland embolization and drug-eluting beads-transarterial chemoembolization in the management of hepatocellular carcinoma: a propensity-score match8
Evolving survival patterns in pancreatic adenocarcinoma: a 23-year retrospective observational analysis8
Comprehension of rectosigmoid junction cancer molecular features by comparison to the rectum or sigmoid colon cancer8
Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma8
The bevacizumab plus oxaliplatin-based chemotherapy regimen is more suitable for metastatic colorectal cancer patients with a history of schistosomiasis: a clinical retrospective analysis8
Comparative study on short-term efficacy of single incision plus one (SI+1) port and multiportal 3D laparoscopic minimally invasive esophagectomy8
RNA-binding protein ENO1 promotes the tumor progression of gastric cancer by binding to and regulating gastric cancer-related genes8
Changing of gamma-H2AX in peripheral blood mononuclear cells during concurrent chemoradiation in locally advanced rectal cancer patients: a potential response predictor8
Prognosis comparison between hepatocellular carcinoma patients with microvascular invasion who received hepatectomy alone and those who underwent early PA-TACE: a retrospective cohort study8
Inflammatory pseudotumor-like extranodal classic Hodgkin lymphoma manifesting as bowel perforation in acquired immunodeficiency syndrome patient with disseminated leishmaniasis: a case report and appr8
High levels of triglycerides, apolipoprotein B, and the number of colorectal polyps are risk factors for colorectal polyp recurrence after endoscopic resection: a retrospective study8
Perioperative lymphocyte-to-monocyte ratio changes plus CA199 in predicting the prognosis of patients with gastric cancer8
Liver resection for hepatocellular carcinoma beyond the BCLC: are multinodular disease, portal hypertension, and portal system invasion real contraindications?7
Efficacy and safety of toripalimab with fruquintinib in the third-line treatment of refractory advanced metastatic colorectal cancer: results of a single-arm, single-center, prospective, phase II clin7
Extent of venous resection during pancreatectomy—finding the balance of technical possibility and feasibility7
Dynamics of neutrophil-to-lymphocyte ratio predict outcomes of metastatic colorectal carcinoma patients treated by FOLFOX7
Effects of recombinant human adenovirus type 5 combined with transarterial chemoembolization on postoperative metastasis and recurrence of hepatocellular carcinoma patients7
Clinicopathologic differences and mortality among Latinos and non-Latino whites with gastric cancer at a majority-minority cancer center in South Texas7
Survival outcome and prognostic factors of remnant gastric cancer: a propensity score-matched analysis7
Development and validation of a dual-energy CT-based model to estimate the malignant probability of distal gastric wall thickening7
ZNF326 as a potential prognostic and predictive biomarker in stage II colorectal cancer7
A retrospective study of clinicopathological characteristics and prognostic factors of Krukenberg tumor with gastric origin7
The clinical outcomes of patients with vascular invasion after deceased donor liver transplantation7
Circ_0007099 upregulates GNG7 to function as a tumor inhibitor in gastric carcinoma by interacting with miR-425-3p7
Candidate oncogene circularNOP10 mediates gastric cancer progression by regulating miR-204/SIRT1 pathway7
Screening of a novel autophagy-related prognostic signature and therapeutic targets in hepatocellular carcinoma7
Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma7
PD-1 inhibition combined with intensity-modulated radiotherapy, to better serve patients with retroperitoneal lymph node metastases from gastrointestinal cancer7
Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment7
Model construction and risk analysis of the lncRNA genes associated with the prognosis of esophageal adenocarcinoma with immune infiltration7
Addition of transarterial chemoembolization improves outcome of tyrosine kinase and immune checkpoint inhibitors regime in patients with unresectable hepatocellular carcinoma7
NOVA2 regulates the properties of liver cancer stem cells and lenvatinib resistance in hepatocellular carcinoma via the Wnt pathway7
The molecular sub-type and the development and validation of a prognosis prediction model based on endocytosis-related genes for hepatocellular carcinoma7
Molecular subtyping and IMScore based on immune-related pathways, oncogenic pathways, and DNA damage repair pathways for guiding immunotherapy in hepatocellular carcinoma patients7
Effect of ramucirumab plus paclitaxel in advanced gastric cancer according to the status of programmed cell death-ligand 1 (PD-L1) expression7
The emerging role of intra-tumoral bacteria7
Correlation analysis of intestinal flora and immune function in patients with primary hepatocellular carcinoma7
Efficacy and safety of dose adjustment for fruquintinib in the third-line treatment of metastatic colorectal cancer: a retrospective study with real-world settings6
A randomized controlled trial of positive end-expiratory pressure on pulmonary oxygenation and biventricular function in esophageal cancer patients receiving one-lung ventilation under a lower FiO26
Efficacy and safety of transarterial chemoembolization-lenvatinib sequential therapy for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study6
Comparison of efficacy and safety between pembrolizumab combined with chemotherapy and simple chemotherapy in neoadjuvant therapy for esophageal squamous cell carcinoma6
Drug-eluting bead transarterial chemoembolization could improve the hepatic hemodynamics of patients with unresectable hepatocellular carcinoma: a retrospective cohort study6
Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer6
Current management of gastric adenocarcinoma: a narrative review6
Cadherin dysregulation in gastric cancer: insights into gene expression, pathways, and prognosis6
The role of TMSB15A in gastric cancer progression and its prognostic significance6
MD2 blockage prevents the migration and invasion of hepatocellular carcinoma cells via inhibition of the EGFR signaling pathway6
Inflammatory bowel disease-associated malignancies and considerations for radiation impacting bowel: a scoping review6
Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis6
Patterns of regional lymph node metastasis predict postoperative overall survival and disease-free survival in locally advanced esophageal squamous cell carcinoma6
Prognostic value of the ratio of carcinoembryonic antigen concentration to maximum tumor diameter in patients with stage II colorectal cancer6
Erratum to Colon cancer-associated transcript-1 enhances glucose metabolism and colon cancer cell activity in a high-glucose environment in vitro and in vivo6
Construction of a competing endogenous RNA network related to the prognosis of cholangiocarcinoma and comprehensive analysis of the immunological correlation6
Patterns-of-care disparities among uninsured versus insured patients with anorectal carcinoma referred for radiotherapy at an Urban Safety-Net Hospital6
Rectal gastrointestinal stromal tumor with metachronous liver metastasis demonstrated no relapse after multidisciplinary team discussion and comprehensive treatment: a case report6
Prospective comparison of positron emission tomography (PET)/magnetic resonance and PET/computed tomography dosimetry in hepatic malignant neoplastic disease after 90Y radioembolization treatment6
Conversion resection of initially unresectable hepatocellular carcinoma associated with steatohepatitis through hepatic artery infusion chemotherapy-transarterial chemoembolization and systemic therap6
ACTR3 promotes cell migration and invasion by inducing epithelial mesenchymal transition in pancreatic ductal adenocarcinoma6
A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line tre6
Pembrolizumab combined with paclitaxel and platinum as induction therapy for locally advanced esophageal squamous cell carcinoma: a retrospective, single-center, three-arm study6
Chemoprotective effect of boeravinone B against 1,2-dimethyl hydrazine induced colorectal cancer in rats via suppression of oxidative stress and inflammatory reaction6
Artemisinin inhibits the development of esophageal cancer by targeting HIF-1α to reduce glycolysis levels6
Lymph node metastasis-related lncRNA GAS6-AS1 facilitates the progression of esophageal squamous cell carcinoma6
Utility and specificity of plasma heat shock protein 90 alpha, CEA, and CA199 as the diagnostic test in colorectal cancer liver metastasis6
Interleukin 13 participates in terminal differentiation of esophageal squamous cell carcinoma cells6
Systematic review and meta-analysis of the prognostic role of fibroblast-activation protein in gastrointestinal cancers6
Hepatoid adenocarcinoma of the stomach: discrimination from conventional gastric adenocarcinoma with a computed tomography-based radiomics nomogram6
Identification of hub genes and functional modules in colon adenocarcinoma based on public databases by bioinformatics analysis6
Luteolin suppresses the growth of colon cancer cells by inhibiting the IL-6/STAT3 signaling pathway6
Transcatheter arterial chemoembolization with tyrosine kinase inhibitor in the 12-year treatment of hepatic metastases from gastrointestinal stromal tumor: a case report6
Clinical application of nano-carbon to improve the accuracy of lymph node staging in patients with advanced gastric cancer receiving neoadjuvant chemotherapy: a prospective randomized controlled trial6
Using an indocyanine green fluorescent imaging technique for laparoscopic rectal cancer surgery: a case report6
BCLC stage C hepatocellular carcinoma: modern therapeutic strategies in the age of immunotherapy6
Regorafenib combined with immune checkpoint inhibitors versus regorafenib monotherapy as a late-line treatment for metastatic colorectal cancer: a single-center, retrospective cohort study6
Impact of occlusal support on postoperative complications in patients with colorectal cancer resections6
Combined detection of preoperative neutrophil to lymphocyte ratio and interleukin-6 as an independent prognostic factor for patients with non-metastatic colorectal cancer6
Circular RNA ZFR promotes cell cycle arrest and apoptosis of colorectal cancer cells via the miR-147a/CACUL1 axis6
Primary gastric squamous cell carcinoma in a young adult with immunotherapy complications: a case report6
A prognostic nomogram based on desmoplastic reaction/tumor deposit modified lymph node staging in colorectal cancer6
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer6
Minimal residual disease monitoring via ctDNA: a case report of Lynch syndrome with synchronous colorectal cancer and review of literature6
Parkinson’s disease and the risk of gastrointestinal cancers: a two-sample Mendelian randomization study6
Prediction and validation of circulating G-quadruplexes as a novel biomarker in colorectal cancer6
Nomogram-based prognostic stratification for patients with large hepatocellular carcinoma: a population study of SEER database and a Chinese cohort6
Surgical microwave ablation for multifocal non-resectable liver metastases: a single institution experience treating five or more liver lesions6
Analysis of the efficacy and safety of paclitaxel (albumin-bound) combined with S-1 and oxaliplatin combined with S-1 in the first-line treatment of advanced gastric cancer: a cohort study5
Identification of potential prognostic biomarkers among gene models for coiled-coil domain-containing family members in hepatocellular carcinoma elucidates their influence on the hypoxia pathway and i5
Machine learning-based analysis identifies a 13-gene prognostic signature to improve the clinical outcomes of colorectal cancer5
Camrelizumab plus sorafenib or apatinib achieved long-term survival in a patient with hepatocellular carcinoma and an Eastern Cooperative Oncology Group performance status of 3: a case report5
Magnetic resonance imaging-based radiomics in predicting the expression of Ki-67, p53, and epidermal growth factor receptor in rectal cancer5
A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological data5
Multiple primary tumors in patients with surgically treated pancreatic cancer: a SEER population-based study5
Is radix ligation of the inferior mesenteric artery effective in Japanese-Style D3 radical lymph node dissection for sigmoid colon and rectal cancer surgery?—a single-center retrospective analysis sin5
Colorectal metastasis from gastric cancer: insights from a 14-year case series at a tertiary hospital5
A surgical nursing perspective analysis of glucose variability in BCLC stage B–C hepatocellular carcinoma patients with and without T2D within 1 year of hepatectomy: a retrospective cohort study from 5
The roles and mechanisms of APOL1 in the development of colorectal cancer5
A dual-targeted molecular therapy of PP242 and cetuximab plays an anti-tumor effect through EGFR downstream signaling pathways in colorectal cancer5
Long-term outcome of metachronous, multiple, early Epstein-Barr virus-associated gastric carcinoma: a case report5
Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma5
Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing5
Resectable, borderline, and locally advanced pancreatic cancer—“the good, the bad, and the ugly” candidates for surgery?5
The expression and clinical value of tumor infiltrating dendritic cells in tumor tissues of patients with esophageal cancer5
A microarray expression profile and bioinformatic analysis of circular RNA in human esophageal carcinoma5
N6-methyladenosine (m6A) regulatory gene divides hepatocellular carcinoma into three subtypes5
Prognostic prediction and gene regulation network of EIF2S2 in hepatocellular carcinoma based on data mining5
Association between preoperative nutritional status, inflammation, and intestinal permeability in elderly patients undergoing gastrectomy: a prospective cohort study5
Circulating lncRNA EGFR-AS1 as a diagnostic biomarker of colorectal cancer and an indicator of tumor burden5
Transarterial chemoembolization for omental vein tumor thrombosis in hepatocellular carcinoma: a case report5
Erratum to lncRNA POT1-AS1 accelerates the progression of gastric cancer by serving as a competing endogenous RNA of microRNA-497-5p to increase PDK3 expression5
CircMMP9 accelerates the progression of hepatocellular carcinoma through the miR-149/CCND2 axis5
Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study5
Promotion of perineural invasion of cholangiocarcinoma by Schwann cells via nerve growth factor5
Outcomes in octogenarians following elective colorectal cancer surgery5
Excellent clinical outcomes can be achieved with neoadjuvant chemoradiation and orthotopic liver transplantation for unresectable cholangiocarcinoma: support for the need of an international transplan5
Morphine promotes angiogenesis by activating PI3K/Akt/HIF-1α pathway and upregulating VEGF in hepatocellular carcinoma5
Identification of a potential competing endogenous RNA (ceRNA) network in gastric adenocarcinoma5
Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients5
Genomic profiles and their associations with microsatellite instability status, tumor mutational burden, and programmed death ligand 1 expression in Chinese patients with colorectal cancer5
Suppression effect and safety of acupuncture on colonic spasm during colonoscopy: a randomized controlled trial5
Gut microbiota modulation: the key to improving outcomes after colorectal cancer surgery?5
Second-line treatment with nivolumab, cabozantinib, regorafenib, or best supportive care in patients with advanced hepatocellular carcinoma: analysis at a Hispanic-majority NCI-designated cancer cente5
Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study5
0.05367112159729